Dyne Therapeutics, Inc. DYN Business Segments
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Research And Development Expense by Product | ||||
| DYNE-101DM1 | $145.08M+95.8% | $74.08M+10.5% | $67.06M+114% | |
| DYNE-251DM1 | $98.93M+9.4% | $90.47M+41.5% | $63.94M+32.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Dyne Therapeutics, Inc. break its business down?
- Dyne Therapeutics, Inc. (DYN) reports research and development expense by product across 2 parts — DYNE-101DM1 and DYNE-251DM1. Each is extracted from the segment footnotes and tracked over time.
- Where does Dyne Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Dyne Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.